… The purpose of this study was to evaluate the incidence of thrombotic events, the risk
factors for the development of thrombosis, and primary thrombosis prevention in aPL-positive …

… Clinical interest in antiphospholipid antibodies is due to their relation with arterial and
venous thrombosis in the antiphospholipid syndrome. Two forms of antiphospholipid syndrome …

… thrombosis. Some prospective studies have likewise failed to produce reliable results since
patients with vascular antiphospholipid syndrome (… to assess risk factors for a first thrombotic …

… Antiphospholipid syndrome (APS) is associated with the risk of both arterial and venous
thrombosis… of antiphospholipid antibody multiple positivity between the groups studied (Table 2). …

… Because of the perceived high risk of recurrent thrombosis in antiphospholipid syndrome …
do not have obvious major risk factors, or in whom recurrent thrombotic events are a feature, …

… Antiphospholipid syndrome (APS) is defined by the persistent presence of moderate/high
serum levels of antiphospholipid antibodies (aPL) in association with thrombotic events or …

… risk factors associated with thrombosis and pregnancy loss in patients with antiphospholipid
antibodies… ) with antiphospholipid antibodies but no thrombosis or pregnancy loss. Venous …

… The antiphospholipid antibody results for the 99 patients in this study are summarized in …
acquired risk factors for thrombosis. Thrombotic events included venous thrombosis (deep vein …

… The combination of aPL with either venous or arterial thrombosis or obstetric complications
is referred to as antiphospholipid syndrome (APS). To fulfil the laboratory criteria of definite …

… , exempt from conventional risk factors of retinal thrombosis. … risk factors for retinal
thrombosis, were prospectively screened for antiphospholipid antibodies (anticardiolipin-antibodies …